CoChat

Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin

Abdoul-Azize, Souleymane, Buquet, Catherine, Li, Hong, Picquenot, Jean-Michel, Vannier, Jean-Pierre · 2018 · Oncogene
Cited by 39

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41388-018-0329-6

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 48

  1. Burridge PW, Li YF, Matsa E, Wu H, Ong SG, Sharma A, et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat Med. 2016;22:547–56. · DOI · Paper page
  2. Ansari L, Shiehzadeh F, Taherzadeh Z, Nikoofal-Sahlabadi S, Momtazi-Borojeni AA, Sahebkar A, et al. The most prevalent side effects of pegylated liposomal doxorubicin monotherapy in women with metastatic breast cancer: a systematic review of clinical trials. Cancer Gene Ther. 2017;24:189–93. · DOI
  3. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Lyu YL, Liu LF, et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012;18:1639–42. · DOI · Paper page
  4. Tombal B, Denmeade SR, Gillis JM, Isaacs JT. A supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosis. Cell Death Differ. 2002;9:561–73. · doi:10.1038/sj.cdd.4400999
  5. Gajek A, Denel-Bobrowska M, Rogalska A, Bukowska B, Maszewski J, Marczak A. Early activation of apoptosis and caspase-independent cell death plays an important role in mediating the cytotoxic and genotoxic effects of WP 631 in ovarian cancer cells. Asian Pac J Cancer Prev. 2015;16:8503–12. · DOI
  6. Szwed M, Laroche-Clary A, Robert J, Jozwiak Z. Efficacy of doxorubicin-transferrin conjugate in apoptosis induction in human leukemia cells through reactive oxygen species generation. Cell Oncol (Dordr). 2016;39:107–18. · DOI
  7. Zhang HT, Wang WW, Ren LH, Zhao XX, Wang ZH, Zhuang DL, et al. The mTORC2/Akt/NFκB pathway-mediated activation of TRPC6 participates in adriamycin-induced podocyte apoptosis. Cell Physiol Biochem. 2016;40:1079–93. · DOI
  8. Gao J, Chen T, Zhao D, Zheng J, Liu Z, Ginkgolide B. Exerts cardioprotective properties against doxorubicin-induced cardiotoxicity by regulating reactive oxygen species, Akt and calcium signaling pathways in vitro and in vivo. PLoS ONE. 2016;11:e0168219. · DOI
  9. Huang X, Xu Y, Liu Y, Xie H, Wang J, Wu Z. Extracellular Ca(2+) selectively enhances adriamycin-induced cell death in human hepatoma cells. Curr Cancer Drug Targets. 2015;15:481–92. · doi:10.2174/156800961506150805151905
  10. Yao H, He G, Yan S, Chen C, Song L, Rosol TJ, et al. Triple-negative breast cancer: is there a treatment on the horizon? Oncotarget. 2017;8:1913–24. · DOI · Paper page
  11. Gazzerro P, Proto MC, Gangemi G, Malfitano AM, Ciaglia E, Pisanti S, et al. Pharmacological actions of statins: a critical appraisal in the management of cancer. Pharmacol Rev. 2012;64:102–46. · DOI · Paper page
  12. Safwat S, Ishak RA, Hathout RM, Mortada ND. Statins anticancer targeted delivery systems: re-purposing an old molecule. J Pharm Pharmacol. 2017;69:613–24. · DOI · Paper page
  13. Kato S, Smalley S, Sadarangani A, Chen-Lin K, Oliva B, Brañes J, et al. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase. J Cell Mol Med. 2010;14:1180–93.
  14. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, et al. Breast cancer growth prevention by statins. Cancer Res. 2006;66:8707–14. · DOI · Paper page
  15. Mortimer JE, Axelrod R, Zimbro K. Effect of statins on breast cancer incidence: findings from the Sentara Health Plan. Proc Am Soc Clin Oncol. 2003;22:93.
  16. Wu QJ, Tu C, Li YY, Zhu J, Qian KQ, Li WJ, et al. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget. 2015;6:42988–3004. · DOI
  17. Katz MS. Therapy Insight: potential of statins for cancer chemoprevention and therapy. Nat Clin Pract Oncol. 2005;2:82–9. · DOI
  18. Borahay MA, Kilic GS, Yallampalli C, Snyder RR, Hankins GD, Al-Hendy A, et al. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells. J Biol Chem. 2014;289:35075–86. · DOI
  19. Mattson MP, Chan SL. Calcium orchestrates apoptosis. Nat Cell Biol. 2003;5:1041–3. · DOI · Paper page
  20. Parekh AB. Store-operated CRAC channels: function in health and disease. Nat Rev Drug Discov. 2010;9:399–410. · DOI · Paper page
  21. Tanwar J, Motiani RK. Role of SOCE architects STIM and Orai proteins in Cell Death. Cell Calcium. 2017;69:19–27. https://doi.org/10.1016/j.ceca.2017.06.002 · DOI
  22. Liao Y, Plummer NW, George MD, Abramowitz J, Zhu MX, Birnbaumer L. A role for Orai in TRPC-mediated Ca2+entry suggests that a TRPC:Orai complex may mediate store and receptor operated Ca2+entry. Proc Natl Acad Sci USA. 2009;106:3202–6. · DOI · Paper page
  23. Motiani RK, Abdullaev IF, Trebak M. A novel native store-operated calcium channel encoded by Orai3: selective requirement of Orai3 versus Orai1 in estrogen receptor-positive versus estrogen receptor-negative breast cancer cells. J Biol Chem. 2010;285:19173–83. · DOI · Paper page
  24. Gogebakan B, Bayraktar R, Suner A, Balakan O, Ulasli M, Izmirli M, et al. Do fasudil and Y-27632 affect the level of transient receptor potential (TRP) gene expressions in breast cancer cell lines? Tumour Biol. 2014;35:8033–41. · DOI
  25. Leung YM, Kwan CY. Current perspectives in the pharmacological studies of store-operated Ca2+entry blockers. Jpn J Pharmacol. 1999;81:253–8. · doi:10.1254/jjp.81.253
  26. Cheng H, Wang S, Feng R. STIM1 plays an important role in TGF-β-induced suppression of breast cancer cell proliferation. Oncotarget. 2016;7:16866–78. · DOI
  27. Mebratu Y, Tesfaigzi Y. How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? Cell Cycle. 2009;8:1168–75. · DOI · Paper page
  28. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym Regul. 1984;22:27–55. · DOI · Paper page
  29. Liu C, Ye Y, Zhou Q, Zhang R, Zhang H, Liu W, et al. Crosstalk between Ca2+signaling and mitochondrial H2O2 is required for rotenone inhibition of mTOR signaling pathway leading to neuronal apoptosis. Oncotarget. 2016;7:7534–49. · DOI
  30. Puthalakath H, O’Reilly LA, Gunn P, Lee L, Kelly PN, Huntington ND, et al. ER stress triggers apoptosis by activating BH3-only protein Bim. Cell. 2007;129:1337–49. · DOI · Paper page
  31. David L, Dulong V, Le Cerf D, Cazin L, Lamacz M, Vannier JP. Hyaluronan hydrogel: An appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater. 2008;4:256–63. · DOI
  32. David L, Dulong V, Le Cerf D, Chauzy C, Norris V, Delpech B, et al. Reticulated hyaluronan hydrogels: a model for examining cancer cell invasion in 3D. Matrix Biol. 2004;23:183–93. · DOI
  33. Marchi S, Pinton P. Alterations of calcium homeostasis in cancer cells. Curr Opin Pharmacol. 2016;29:1–6. · DOI
  34. Ouadid-Ahidouch H, Dhennin-Duthille I, Gautier M, Sevestre H, Ahidouch A. TRP channels: diagnostic markers and therapeutic targets for breast cancer? Trends Mol Med. 2013;19:117–24. · DOI
  35. Shi J, Miralles F, Birnbaumer L, Large WA, Albert AP. Store-operated interactions between plasmalemmal STIM1 and TRPC1 proteins stimulate PLCβ1 to induce TRPC1 channel activation in vascular smooth muscle cells. J Physiol. 2017;595:1039–58. · doi:10.1113/jp273302
  36. Giorgi C, Bonora M, Sorrentino G, Missiroli S, Poletti F, Suski JM, et al. p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+ -dependent manner. Proc Natl Acad Sci USA. 2015;112:1779–84. · DOI · Paper page
  37. Zhang S, Chen Y, Wu X, Gao H, Ma R, Jiang C, et al. The pivotal role of Ca2+homeostasis in PBDE-47-induced neuronal apoptosis. Mol Neurobiol. 2016;53:7078–88. · DOI
  38. Tiwari M, Prasad S, Shrivastav TG, Chaube SK. Calcium signaling during meiotic cell cycle regulation and apoptosis in mammalian oocytes. J Cell Physiol. 2017;232:976–81. · DOI
  39. Vashisht A, Trebak M, Motiani RK. STIM and Orai proteins as novel targets for cancer therapy. A review in the theme: cell and molecular processes in cancer metastasis. Am J Physiol Cell Physiol. 2015;309:C457–69. · DOI
  40. Yang S, Zhang JJ, Huang XY. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell. 2009;15:124–34. · DOI · Paper page
  41. Li Y, Liu H, Huang YY, Pu LJ, Zhang XD, Jiang CC, et al. Suppression of endoplasmic reticulum stress-induced invasion and migration of breast cancer cells through the downregulation of heparanase. Int J Mol Med. 2013;31:1234–42. · DOI
  42. Einbond LS, Wu HA, Sandu C, Ford M, Mighty J, Antonetti V, et al. Digitoxin enhances the growth inhibitory effects of thapsigargin and simvastatin on ER negative human breast cancer cells. Fitoterapia. 2016;109:146–54. · DOI
  43. Lavik AR, Zhong F, Chang MJ, Greenberg E, Choudhary Y, Smith MR, et al. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget. 2015;6:27388–402. · DOI
  44. Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA. 2004;101:15313–17. · DOI · Paper page
  45. Rambal AA, Panaguiton ZL, Kramer L, Grant S, Harada H. MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM. Leukemia. 2009;23:1744–54. · DOI · Paper page
  46. Buranrat B, Suwannaloet W, Naowaboot J. Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells. Oncol Lett. 2017;14:6243–50.
  47. Simon T, Coquerel B, Petit A, Kassim Y, Demange E, Le Cerf D, et al. Direct effect of bevacizumab on glioblastoma cell lines in vitro. Neuromolecular Med. 2014;16:752–71. · DOI
  48. Abdoul-Azize S, Dubus I, Vannier JP. Improvement of dexamethasone sensitivity by chelation of intracellular Ca2+ in pediatric acute lymphoblastic leukemia cells through the prosurvival kinase ERK1/2 deactivation. Oncotarget. 2017;8:27339–52. · DOI

Cited by

See all 39

Metadata

Authors
Abdoul-Azize, S., Buquet, C., Li, H., Picquenot, J.-M., & Vannier, J.-P.
Venue
Oncogene
Published
2018-05-23
Volume
37
Issue
36
Pages
4979-4993
ISSN
  • 0950-9232
  • 1476-5594
Cited by
39
References
3
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. https://app.cochat.ai/papers/10.1038/s41388-018-0329-6
The paper
Abdoul-Azize, S., Buquet, C., Li, H., Picquenot, J.-M., & Vannier, J.-P. (2018). Integration of Ca2+ signaling regulates the breast tumor cell response to simvastatin and doxorubicin. Oncogene. https://doi.org/10.1038/s41388-018-0329-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.